Diabetes Mellitus  >>  ISIS 388626  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ISIS 388626 / Ionis
NCT00836225: Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers

Completed
1
103
Europe
ISIS 388626
Ionis Pharmaceuticals, Inc.
Type 2 Diabetes Mellitus
10/11
01/12

Download Options